Rici Healthcare Holdings Limited
Rici Healthcare Holdings Limited Fundamental Analysis
Rici Healthcare Holdings Limited (1526.HK) shows moderate financial fundamentals with a PE ratio of 4.21, profit margin of 12.52%, and ROE of 18.05%. The company generates $2.2B in annual revenue with weak year-over-year growth of -2.28%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 38.1/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze 1526.HK's fundamental strength across five key dimensions:
Efficiency Score
Weak1526.HK struggles to generate sufficient returns from assets.
Valuation Score
Excellent1526.HK trades at attractive valuation levels.
Growth Score
Weak1526.HK faces weak or negative growth trends.
Financial Health Score
Weak1526.HK carries high financial risk with limited liquidity.
Profitability Score
Moderate1526.HK maintains healthy but balanced margins.
Key Financial Metrics
Is 1526.HK Expensive or Cheap?
P/E Ratio
1526.HK trades at 4.21 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, 1526.HK's PEG of 0.77 indicates potential undervaluation.
Price to Book
The market values Rici Healthcare Holdings Limited at 0.70 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 0.36 times EBITDA. This is generally considered low.
How Well Does 1526.HK Make Money?
Net Profit Margin
For every $100 in sales, Rici Healthcare Holdings Limited keeps $12.52 as profit after all expenses.
Operating Margin
Core operations generate 25.89 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $18.05 in profit for every $100 of shareholder equity.
ROA
Rici Healthcare Holdings Limited generates $5.63 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Rici Healthcare Holdings Limited produces operating cash flow of $358.36M, showing steady but balanced cash generation.
Free Cash Flow
Rici Healthcare Holdings Limited generates strong free cash flow of $311.62M, providing ample flexibility for dividends, buybacks, or growth.
FCF Per Share
Each share generates $0.20 in free cash annually.
FCF Yield
1526.HK converts 26.90% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
4.21
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
0.77
vs 25 benchmark
P/B Ratio
Price to book value ratio
0.70
vs 25 benchmark
P/S Ratio
Price to sales ratio
0.53
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
1.22
vs 25 benchmark
Current Ratio
Current assets to current liabilities
0.98
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.18
vs 25 benchmark
ROA
Return on assets percentage
0.06
vs 25 benchmark
ROCE
Return on capital employed
0.18
vs 25 benchmark
How 1526.HK Stacks Against Its Sector Peers
| Metric | 1526.HK Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 4.21 | 28.45 | Better (Cheaper) |
| ROE | 18.05% | 763.00% | Weak |
| Net Margin | 12.52% | -45265.00% (disorted) | Strong |
| Debt/Equity | 1.22 | 0.34 | Weak (High Leverage) |
| Current Ratio | 0.98 | 2795.60 | Weak Liquidity |
| ROA | 5.63% | -16588.00% (disorted) | Weak |
1526.HK outperforms its industry in 2 out of 6 key metrics, particularly excelling in Net Margin, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Rici Healthcare Holdings Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
69.51%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
530.12%
Industry Style: Defensive, Growth, Innovation
High GrowthFCF CAGR
379.32%
Industry Style: Defensive, Growth, Innovation
High Growth